Editorial: Cognate recognition, functional properties and immunotherapeutic applications of iNKT cells: leveling the road to the clinic.
作者信息
Castaño A Raul, Porcelli Steven Anthony
机构信息
Department of Cellular Biology, Physiology and Immunology, Autonomous University of Barcelona, Barcelona, Spain.
Department of Microbiology & Immunology, Albert Einstein College of Medicine, New York City, NY, United States.
出版信息
Front Immunol. 2025 Jan 23;16:1552225. doi: 10.3389/fimmu.2025.1552225. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Cognate recognition, functional properties and immunotherapeutic applications of iNKT cells: leveling the road to the clinic.社论：不变自然杀伤T细胞的同源识别、功能特性及免疫治疗应用：迈向临床的道路铺平
Front Immunol. 2025 Jan 23;16:1552225. doi: 10.3389/fimmu.2025.1552225. eCollection 2025.
2
The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.BV8S2（Vβ8.2）的互补决定区2有助于大鼠恒定自然杀伤T细胞TCR对抗原的识别。
J Immunol. 2006 Jun 15;176(12):7447-55. doi: 10.4049/jimmunol.176.12.7447.
3
Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.不变自然杀伤 T 细胞：糖脂抗原免疫治疗靶标的潜力。
Immunotherapy. 2011 Jan;3(1):59-75. doi: 10.2217/imt.10.85.
4
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.基于CD1d不变自然杀伤T细胞的癌症免疫疗法：α-半乳糖神经酰胺及其他。
Front Immunol. 2018 Jul 2;9:1519. doi: 10.3389/fimmu.2018.01519. eCollection 2018.
5
Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner.抗 Vα24Jα18TCR 抗体以 FcγRII（CD32）依赖性方式调节 iNKT 细胞应答以靶向和杀伤 CD1d 阴性肿瘤。
Cancer Res Commun. 2024 Feb 19;4(2):446-459. doi: 10.1158/2767-9764.CRC-23-0203.
6
The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.人类非 Vα24 T 细胞受体识别 CD1d/α-半乳糖神经酰胺的分子基础。
PLoS Biol. 2012;10(10):e1001412. doi: 10.1371/journal.pbio.1001412. Epub 2012 Oct 23.
7
Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.激活的不变自然杀伤 T 细胞以 CD1d 非依赖性的方式直接识别白血病细胞。
Cancer Sci. 2020 Jul;111(7):2223-2233. doi: 10.1111/cas.14428. Epub 2020 Jun 19.
8
Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.α-半乳糖神经酰胺-CD1d 复合物单抗识别 CD1d 呈递 β-甘露糖神经酰胺的结构-功能意义。
Front Immunol. 2019 Oct 9;10:2355. doi: 10.3389/fimmu.2019.02355. eCollection 2019.
9
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.嵌合抗原受体修饰的不变自然杀伤 T 细胞治疗多发性骨髓瘤的临床前评价
Int J Mol Sci. 2021 Jan 22;22(3):1096. doi: 10.3390/ijms22031096.
10
Immunotherapeutic potential for ceramide-based activators of iNKT cells.基于神经酰胺的iNKT细胞激活剂的免疫治疗潜力。
Trends Pharmacol Sci. 2005 May;26(5):252-7. doi: 10.1016/j.tips.2005.03.005.
本文引用的文献
1
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.从造血干细胞工程化制备异体反应性 CAR-NKT 细胞用于现货型癌症免疫治疗。
Mol Ther. 2024 Jun 5;32(6):1849-1874. doi: 10.1016/j.ymthe.2024.04.005. Epub 2024 Apr 6.
2
Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients.未经编辑的同种异体 iNKT 细胞在 MHC 错配的犬受体内具有延长的持久性。
Cell Rep Med. 2023 Oct 17;4(10):101241. doi: 10.1016/j.xcrm.2023.101241.
3
A humanized mouse model for evaluation of invariant Natural Killer T cell responses.用于评估不变自然杀伤 T 细胞反应的人源化小鼠模型。
Front Immunol. 2022 Oct 3;13:1011209. doi: 10.3389/fimmu.2022.1011209. eCollection 2022.
4
Host immunomodulatory lipids created by symbionts from dietary amino acids.由饮食中的氨基酸产生的共生体宿主免疫调节脂质。
Nature. 2021 Dec;600(7888):302-307. doi: 10.1038/s41586-021-04083-0. Epub 2021 Nov 10.
5
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead.NKT细胞免疫疗法的现状与未来挑战
Cancers (Basel). 2021 Oct 15;13(20):5174. doi: 10.3390/cancers13205174.
6
iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.iNKT 细胞协调免疫途径，使非条件宿主能够植入。
Life Sci Alliance. 2021 Jun 10;4(7). doi: 10.26508/lsa.202000999. Print 2021 Jul.
7
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects.不变自然杀伤 T 细胞亚群具有不同的移植物抗宿主病预防和抗肿瘤作用。
Blood. 2021 Sep 9;138(10):858-870. doi: 10.1182/blood.2021010887.
8
Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.新型非糖基化 I 型 NKT 激动剂的结构和功能表征及其免疫调节特性。
J Immunol. 2012 Mar 1;188(5):2254-65. doi: 10.4049/jimmunol.1103049. Epub 2012 Feb 1.
9
Distinct functional lineages of human V(alpha)24 natural killer T cells.人类V(α)24自然杀伤T细胞的不同功能谱系。
J Exp Med. 2002 Mar 4;195(5):637-41. doi: 10.1084/jem.20011908.
10
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.糖基神经酰胺通过CD1d限制和TCR介导激活Vα14自然杀伤T细胞
Science. 1997 Nov 28;278(5343):1626-9. doi: 10.1126/science.278.5343.1626.
Zotero 插件